Table 2.
Baseline characteristics of subjects in the acute exercise study
| Control subjects | Youth with type 2 diabetes | |
|---|---|---|
| n | 7 | 12 |
| Male:female ratio | 2:5 | 10:2 |
| Age (years) | 26 ± 2 | 27 ± 1 |
| Duration of diabetes (years) | NA | 2.5 ± 0.7 |
| Treatment for diabetes | NA | Met 9; Met/Ins 2; Diet 3 |
| Weight (kg) | 113.9 ± 11.2 | 114.5 ± 7.3 |
| BMI (kg/m2) | 39.13 ± 2.54 | 36.13 ± 1.78 |
| Systolic blood pressure (mmHg) | 117 ± 3 | 127 ± 4 |
| Diastolic blood pressure (mmHg) | 75 ± 4 | 81 ± 3 |
| Waist circumference (cm) | 120.2 ± 6.1 | 111.4 ± 4.8 |
| Waist-to-hip ratio | 0.98 ± 0.03 | 0.99 ± 0.02 |
| A1C (%) | 5.6 ± 0.1 | 7.5 ± 0.5† |
| Fasting glucose (mmol/l) | 5.2 ± 0.1 | 8.0 ± 0.7† |
| Fasting insulin (pmol/l) | 163.0 ± 65.3 | 169.6 ± 61.7 |
| Fasting C-peptide (μg/l) | 5.3 ± 1.2 | 3.4 ± 0.4* |
| Total cholesterol (mmol/l) | 4.13 ± 0.32 | 4.29 ± 0.26 |
| HDL (mmol/l) | 1.30 ± 0.17 | 0.95 ± 0.05* |
| LDL (mmol/l) | 2.21 ± 0.29 | 2.63 ± 0.28 |
| Triglycerides (mmol/l) | 1.35 ± 0.20 | 1.76 ± 0.26 |
| Free fatty acids (mmol/l) | 0.67 ± 0.16 | 0.77 ± 0.22 |
| Vo2max (ml · kg−1 · min−1) | 22.85 ± 2.71 | 23.79 ± 1.79 |
Data are means ± SE, unless specified otherwise.
*Significantly different from control group (P < 0.05).
†Significantly different from control group (P < 0.01). Ins, insulin; Met, metformin.